Filip Janku

Chief Tech/Sci/R&D Officer at MONTE ROSA THERAPEUTICS, INC.

Net worth: 1 M $ as of 2026-05-30

52 year

Consumer Services

Health Technology

Profile

Filip Janku is currently Chief Medical Officer at Monte Rosa Therapeutics, Inc. since 2021.
Formerly, served as Center Medical Director & Associate Professor at The University of Texas M.D.
Anderson Cancer Center from 2012 to 2021.
Education includes a doctorate from the University of Charles.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
MONTE ROSA THERAPEUTICS, INC. 0.07%	2026-06-29	60,612 ( 0.07% )	1 M $	2026-05-30

Filip Janku active positions

Companies	Position	Start
MONTE ROSA THERAPEUTICS, INC.	Chief Tech/Sci/R&D Officer	2021-05-31

All active positions of Filip Janku

Former positions of Filip Janku

Companies	Position	End
The University of Texas M.D. Anderson Cancer Center The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer	Corporate Officer/Principal	2021-04-30

See the detail of Filip Janku's experience

Training of Filip Janku

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Filip Janku's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
The University of Texas M.D. Anderson Cancer Center The University of Texas M.D. Anderson Cancer Center Other Consumer ServicesConsumer Services Provides cancer patient care, research and prevention for cancer	Consumer Services
University of Charles University of Charles Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Monte Rosa Therapeutics, Inc. Monte Rosa Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops molecular glue degrader medicines for oncology, autoimmune and inflammatory diseases	Health Technology